Abstract
To further understand the role of XIAP in acute myeloid leukemia (AML), we suppressed XIAP expression by antisense oligonucleotides and determined the effect on gene expression profiles and biological pathways. XIAP inhibition upregulated expression of proteasome genes in a manner similar to the proteasome inhibitor bortezomib or MG132; decreased 20S proteasome activity, an effect which was diminished in the presence of a pan-caspase inhibitor; and increased IκBα, Mcl-1, and HSP70 in AML cells. In addition to multiple functions already described, XIAP contributes to increased proteasome activity in AML cells, and the antitumor effect of XIAP inhibition may be mediated in part through caspase-dependent proteasome inhibition.
Original language | English (US) |
---|---|
Pages (from-to) | 974-979 |
Number of pages | 6 |
Journal | Leukemia Research |
Volume | 37 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2013 |
Keywords
- AML
- Caspase
- Gene expression
- IκBα
- Proteasome
- XIAP
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
MD Anderson CCSG core facilities
- Flow Cytometry and Cellular Imaging Facility